Get the Stockscreener App
277.51
0.75%
-2.11
After Hours:
277.51
Overview
News
Price History
Option Chain
Financials
Why LH Down?
Discussions
Forecast
Stock Split
Dividend History
Labcorp Holdings Inc stock is traded at $277.51, with a volume of 575.37K.
It is down -0.75% in the last 24 hours and up +0.11% over the past month.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
See More
Previous Close:
$279.62
Open:
$279.26
24h Volume:
575.37K
Relative Volume:
0.95
Market Cap:
$23.06B
Revenue:
$13.48B
Net Income/Loss:
$764.50M
P/E Ratio:
30.60
EPS:
9.0688
Net Cash Flow:
$1.26B
1W Performance:
-0.56%
1M Performance:
+0.11%
6M Performance:
+27.49%
1Y Performance:
+30.49%
1-Day Range:
$275.18
$280.16
1-Week Range:
$273.45
$283.69
52-Week Range:
$209.38
$289.19
Labcorp Holdings Inc Stock (LH) Company Profile
Name
Labcorp Holdings Inc
Sector
Industry
Phone
(336) 229-1127
Address
358 S MAIN ST, BURLINGTON, NC
Compare LH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
277.51 | 23.24B | 13.48B | 764.50M | 1.26B | 9.0688 |
|
TMO
Thermo Fisher Scientific Inc
|
536.19 | 203.60B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
204.96 | 149.49B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
629.91 | 50.19B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
140.81 | 39.28B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
200.60 | 34.15B | 15.70B | 1.24B | 2.01B | 6.9036 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-10-25 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-02-25 | Initiated | Redburn Atlantic | Buy |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-30-24 | Upgrade | HSBC Securities | Hold → Buy |
| Oct-01-24 | Initiated | Piper Sandler | Neutral |
| Mar-25-24 | Upgrade | Argus | Hold → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Initiated | Evercore ISI | In-line |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-19-22 | Downgrade | Argus | Buy → Hold |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-11-21 | Upgrade | Argus | Hold → Buy |
| Jan-11-21 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Jan-08-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-13-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-02-20 | Resumed | Deutsche Bank | Buy |
| May-15-20 | Upgrade | Mizuho | Neutral → Buy |
| Apr-29-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jul-16-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jun-21-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Jan-17-19 | Initiated | UBS | Buy |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-30-18 | Downgrade | Argus | Buy → Hold |
| Oct-25-18 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-19-18 | Resumed | BofA/Merrill | Buy |
| Jun-07-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| May-01-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-23-18 | Initiated | Argus | Buy |
View All
Labcorp Holdings Inc Stock (LH) Latest News
Labcorp Declares Quarterly Dividend - GuruFocus
Labcorp Holdings Inc. (NYSE:LH) Announces $0.72 Quarterly Dividend - MarketBeat
Labcorp Holdings Declares Cash Dividend Announcement - TipRanks
Labcorp Keeps Quarterly Dividend at $0.72 a Share, Payable Dec. 11 to Shareholders of Record on Nov. 26 - MarketScreener
Labcorp declares quarterly dividend of $0.72 per share By Investing.com - Investing.com Australia
Leerink Partners Adjusts Labcorp Price Target to $342 From $323, Maintains Outperform Rating - MarketScreener
Labcorp Holdings Getting Closer To Key Technical Measure - MSN
Former LabCorp Diagnostics CEO Gary Huff joins Biomerica board By Investing.com - Investing.com Canada
Gary Huff Joins Biomerica Board as Independent Director — Former LabCorp Diagnostics CEO to Advise Growth - Stock Titan
Navera Investment Management Ltd. Lowers Position in Labcorp Holdings Inc. $LH - MarketBeat
Robeco Institutional Asset Management B.V. Sells 7,203 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Labcorp Holdings’ Q3 2025 Earnings: What To Expect - Barchart.com
What drives Labcorp Holdings Inc N6B stock priceHigh Dividend Yield Stocks & 100% Free Stock Analysis for Smarter Decisions - earlytimes.in
QRG Capital Management Inc. Lowers Position in Labcorp Holdings Inc. $LH - MarketBeat
Is Labcorp Holdings Inc N6B a good long term investmentDividend Aristocrats List & Free Triple Digit Wealth Increase - earlytimes.in
Why Labcorp Holdings Inc. stock could outperform next yearGlobal Markets & Fast Gain Stock Tips - newser.com
Will Labcorp Holdings Inc. (N6B) stock remain on Wall Street radarEarnings Beat & Stock Portfolio Risk Control - newser.com
Hunter Perkins Capital Management LLC Sells 8,292 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Historical volatility pattern of Labcorp Holdings Inc. visualizedJuly 2025 Trends & Stepwise Trade Signal Implementation - newser.com
Will Labcorp Holdings Inc. stock extend growth story2025 Trading Recap & Low Risk High Win Rate Picks - newser.com
Will Labcorp Holdings Inc. (N6B) stock sustain dividend payoutsPortfolio Profit Report & Long-Term Growth Plans - newser.com
J. Safra Sarasin Holding AG Decreases Stock Position in Labcorp Holdings Inc. $LH - MarketBeat
Labcorp price target raised to $305 from $300 at Evercore ISI - Yahoo Finance
Hilltop National Bank Buys Shares of 980 Labcorp Holdings Inc. $LH - MarketBeat
Capital Investment Advisors LLC Invests $323,000 in Labcorp Holdings Inc. $LH - MarketBeat
Labcorp Holdings (LH) Sees Analyst Rating Maintained and Price T - GuruFocus
Relative strength of Labcorp Holdings Inc. in sector analysisTrade Analysis Summary & Daily Profit Focused Stock Screening - newser.com
Evercore ISI Adjusts PT on Labcorp Holdings to $305 From $300, Maintains Outperform Rating - MarketScreener
Can Labcorp Holdings Inc. stock hit consensus price targetsOptions Play & Weekly Breakout Watchlists - newser.com
How Labcorp Holdings Inc. stock reacts to Fed tighteningPortfolio Risk Summary & Low Drawdown Momentum Trade Ideas - newser.com
Barclays Maintains Labcorp Holdings (LH) Equal-Weight Recommendation - Nasdaq
Labcorp Holdings Hits New 52-Week High of $289.19 - Markets Mojo
Barclays Maintains Equal-Weight Rating on Labcorp (LH), Raises P - GuruFocus
Barclays Adjusts Price Target on Labcorp to $290 From $275, Maintains Equalweight Rating - MarketScreener
AMI Asset Management Corp Sells 11,313 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Labcorp Holdings Hits New 52-Week High at $288.24 - Markets Mojo
How reliable is Labcorp Holdings Inc. (N6B) stock dividend growth2025 EndofYear Setup & Growth Focused Stock Pick Reports - newser.com
Bartlett & CO. Wealth Management LLC Has $55.34 Million Stake in Labcorp Holdings Inc. $LH - MarketBeat
Labcorp Holdings stock hits 52-week high at 284.88 USD By Investing.com - Investing.com Nigeria
Labcorp Holdings stock hits 52-week high at 284.88 USD - Investing.com
Labcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities - MarketScreener
Labcorp to Collaborate With Roche to Advance Digital Pathology Capabilities - MarketScreener
Labcorp to implement Roche’s digital pathology scanners amid pathologist shortage - Investing.com Canada
Labcorp announces collaboration with Roche to advance digital pathology capabilities - MarketScreener
Labcorp Holdings Inc Stock (LH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.11%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):